Valerie Y Chock1, Irene J Chang, V Mohan Reddy. 1. Department of Pediatrics, Division of Neonatal and Developmental Medicine, Stanford University School of Medicine and Lucile Packard Children's Hospital, Palo Alto, Calif, USA. vchock@stanford.edu
Abstract
OBJECTIVE: The objective of this study was to determine neurodevelopmental outcomes up to 30 months of age in a cohort of neonates requiring surgical intervention without circulatory arrest for congenital heart disease and to correlate these outcomes with characteristics detected prior to hospital discharge. DESIGN AND SETTING: An observational cohort of surviving neonates who underwent surgical intervention without circulatory arrest for congenital heart disease between 2002 and 2003 was studied at a single tertiary care institution. PATIENTS: Thirty-five patients were followed from 4 to 6 months of age until 24-30 months of age. OUTCOME MEASURES: Neuromotor abnormalities, use of special services, and degree of developmental delay at set intervals between 4 and 30 months of age were retrospectively obtained from clinical reports. The relationship between these outcomes and clinical characteristics prior to hospital discharge was analyzed. RESULTS: Those with neuromotor abnormalities prior to discharge were likely to have persistent abnormalities in muscle strength, tone, and symmetry until 4-6 months of age, odds ratio 6 (1.3-29). By 24-30 months of age, motor abnormalities or developmental delay occurred in 10 of 20 infants (50%), but were no longer significantly associated with predischarge findings. CONCLUSIONS: Infants undergoing surgical intervention for congenital heart disease are at risk for neurodevelopmental abnormalities, which may not become apparent until months after hospital discharge. Early impairment may also resolve over time. Close developmental follow-up in this high-risk cohort of patients is warranted.
OBJECTIVE: The objective of this study was to determine neurodevelopmental outcomes up to 30 months of age in a cohort of neonates requiring surgical intervention without circulatory arrest for congenital heart disease and to correlate these outcomes with characteristics detected prior to hospital discharge. DESIGN AND SETTING: An observational cohort of surviving neonates who underwent surgical intervention without circulatory arrest for congenital heart disease between 2002 and 2003 was studied at a single tertiary care institution. PATIENTS: Thirty-five patients were followed from 4 to 6 months of age until 24-30 months of age. OUTCOME MEASURES: Neuromotor abnormalities, use of special services, and degree of developmental delay at set intervals between 4 and 30 months of age were retrospectively obtained from clinical reports. The relationship between these outcomes and clinical characteristics prior to hospital discharge was analyzed. RESULTS: Those with neuromotor abnormalities prior to discharge were likely to have persistent abnormalities in muscle strength, tone, and symmetry until 4-6 months of age, odds ratio 6 (1.3-29). By 24-30 months of age, motor abnormalities or developmental delay occurred in 10 of 20 infants (50%), but were no longer significantly associated with predischarge findings. CONCLUSIONS:Infants undergoing surgical intervention for congenital heart disease are at risk for neurodevelopmental abnormalities, which may not become apparent until months after hospital discharge. Early impairment may also resolve over time. Close developmental follow-up in this high-risk cohort of patients is warranted.
Authors: Stephanie Fuller; Ramakrishnan Rajagopalan; Gail P Jarvik; Marsha Gerdes; Judy Bernbaum; Gil Wernovsky; Robert R Clancy; Cynthia Solot; Susan C Nicolson; Thomas L Spray; J William Gaynor Journal: Ann Thorac Surg Date: 2010-12 Impact factor: 4.330
Authors: Catherine L Dent; James P Spaeth; Blaise V Jones; Steven M Schwartz; Tracy A Glauser; Barbara Hallinan; Jeffrey M Pearl; Philip R Khoury; C Dean Kurth Journal: J Thorac Cardiovasc Surg Date: 2005-12 Impact factor: 5.209
Authors: J William Gaynor; Susan C Nicolson; Gail P Jarvik; Gil Wernovsky; Lisa M Montenegro; Nancy B Burnham; Diane M Hartman; Andy Louie; Thomas L Spray; Robert R Clancy Journal: J Thorac Cardiovasc Surg Date: 2005-10-13 Impact factor: 5.209
Authors: Caren S Goldberg; Edward L Bove; Eric J Devaney; Eileen Mollen; Edward Schwartz; Shauna Tindall; Cheryl Nowak; John Charpie; Morton B Brown; Tom J Kulik; Richard G Ohye Journal: J Thorac Cardiovasc Surg Date: 2007-02-22 Impact factor: 5.209
Authors: Karen J Visconti; David Rimmer; Kimberlee Gauvreau; Pedro del Nido; John E Mayer; Ikou Hagino; Frank A Pigula Journal: Ann Thorac Surg Date: 2006-12 Impact factor: 4.330
Authors: Allison Levey; Julie S Glickstein; Charles S Kleinman; Stephanie M Levasseur; Jonathan Chen; Welton M Gersony; Ismee A Williams Journal: Pediatr Cardiol Date: 2010-02-18 Impact factor: 1.655
Authors: Stephanie Fuller; Alex S Nord; Marsha Gerdes; Gil Wernovsky; Gail P Jarvik; Judy Bernbaum; Elaine Zackai; James William Gaynor Journal: Eur J Cardiothorac Surg Date: 2009-04-25 Impact factor: 4.191
Authors: J William Gaynor; Gil Wernovsky; Gail P Jarvik; Judy Bernbaum; Marsha Gerdes; Elaine Zackai; Alex S Nord; Robert R Clancy; Susan C Nicolson; Thomas L Spray Journal: J Thorac Cardiovasc Surg Date: 2007-03-19 Impact factor: 5.209
Authors: Aymen N Naguib; Peter D Winch; Joseph D Tobias; Keith O Yeates; Yongjie Miao; Mark Galantowicz; Timothy M Hoffman Journal: Saudi J Anaesth Date: 2015-01